A Phase I Trial of BKM120 (Buparlisib) in Combination with Fulvestrant in Postmenopausal Women with Estrogen Receptor-Positive Metastatic Breast Cancer

Publication date: 2016 Source:Breast Diseases: A Year Book Quarterly, Volume 27, Issue 4 Author(s): A.M. Schram, M.N. Dickler
Source: Breast Diseases: A Year Book Quarterly - Category: Cancer & Oncology Source Type: research